Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Targeted combination of poly (ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors lacking evidence of benefit: focus in ovarian cancer
M Bailey, S Morand, R Royfman, L Lin, A Singh… - International Journal of …, 2024 - mdpi.com
The emergence of targeted therapeutics in ovarian cancer, particularly poly (ADP-ribose)
polymerase inhibitors (PARPi's), has created additional opportunities for patients seeking …
polymerase inhibitors (PARPi's), has created additional opportunities for patients seeking …
Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China
R Du, X Wang, L Ma, LM Larcher, H Tang, H Zhou… - BMC cancer, 2021 - Springer
Abstract Background The adverse reactions (ADRs) of targeted therapy were closely
associated with treatment response, clinical outcome, quality of life (QoL) of patients with …
associated with treatment response, clinical outcome, quality of life (QoL) of patients with …
The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy
R Du, H Yang, H Zhou, L Ma, MA Getu, C Chen… - BMC cancer, 2022 - Springer
Background High medication literacy is the basis of rational medication application and is
essential for the management of severe adverse drug reactions. The objective of the present …
essential for the management of severe adverse drug reactions. The objective of the present …
The health-related quality of life of lung cancer patients with EGFR-TKI-related skin adverse drug reactions and its relationship with co** style and self-management
R Du, X Wang, H Zhou, L Ma, LM Larcher… - Supportive Care in …, 2022 - Springer
Purpose The status and associated factors of the health-related quality of life of non-small-
cell lung cancer (NSCLC) patients under targeted anti-cancer therapy have not been …
cell lung cancer (NSCLC) patients under targeted anti-cancer therapy have not been …
[HTML][HTML] Experience of patients with lung cancer and with targeted therapy-related skin adverse drug reactions: a qualitative study
R Du, H Yang, J Zhu, H Zhou, L Ma, MA Getu… - Asia-Pacific journal of …, 2022 - Elsevier
Objective To explore the experience of non-small-cell lung cancer patients with targeted
therapy-related skin adverse drug reactions. Methods This is a descriptive quantitative study …
therapy-related skin adverse drug reactions. Methods This is a descriptive quantitative study …
Home-based multidisciplinary interventions on skin adverse reactions in EGFR-TKI-treated patients with lung cancer: a protocol for a randomised controlled trial
R Du, H Yang, H Zhou, L Ma, MA Getu, C Chen… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Here, we provide a feasible, well-designed protocol of a randomised controlled
trial for the assessment of the effects of a home-based multidisciplinary intervention on the …
trial for the assessment of the effects of a home-based multidisciplinary intervention on the …
Analysis of Influence Factors of Quality of Life of Lung Cancer Patients with Skin Adverse Drug Reactions Under Targeted Therapy
R Du, X Wang, H Zhou, L Ma, LM Larcher, C Chen… - 2022 - researchsquare.com
Purpose This study was to assess the status of quality of life and explore the possible factors
correlated with quality of life among non-small cell lung cancer (NSCLC) patients with skin …
correlated with quality of life among non-small cell lung cancer (NSCLC) patients with skin …